Skip to content
Search

Latest Stories

GP appointments could grow by 70 million a year if pharmacies disappear: NPA survey

GP appointments could grow by 70 million a year if pharmacies disappear: NPA survey
pharmacy closures

A substantial, sustained new funding is needed to keep pharmacy doors open and keep pressure off the NHS  

A survey by the National Pharmacy Association (NPA) has highlighted the impact of widespread pharmacy closures in England, which is likely to increase the demand for general practice (GP) appointments by millions.


Over a thousand pharmacies have been closed in England since 2017, with about 10,700 remaining open now.

Currently, GP provides approximately 300 million patient consultations each year, but their demand is set to grow by millions if pharmacies continue to disappear.

In the NPA survey, 64 per cent of UK adults said they would go to their GP more often for advice and treatment if their local pharmacies closed.

A third (34 per cent) of the respondents said they would visit their doctor at least twice more each year, including some who would go on more than 10 extra occasions.

This means there could be between 69 million and 100 million more GP appointments, if all “local” pharmacies in England were to close, the survey suggested.

Nick Kaye, Chair of the NPA, said: “The wait to see your GP or even A&E will inevitably grow if the pharmacy network continues to shrink. Pharmacies currently advise and treat millions of people a year who would otherwise go to their doctor. Patients are the biggest losers from pharmacy closures, having to make longer journeys and waiting longer for treatment, or missing out altogether.

“The government and NHS need to inject substantial, sustained new funding into community pharmacy, to keep pharmacy doors open and keep pressure off other parts of the NHS.”

The associated also cited a 2020 study by Ernst and Young (EY) which predicted that 72 per cent of family-owned pharmacies could be loss making by the end of 2024 if the current funding arrangements remain unchanged.

The Pharmacy First service, which is due to begin across England in late January 2024, is likely to make life easier for patients as well as reduce pressure in the NHS.

The advanced service is designed to improve access to primary care by allowing pharmacists to provide NHS advice and treatments for common ailments like sore throat, shingles and urinary tract infections without the patient needing to visit their GP for a prescription.

Screenshot 2023 12 12 161836

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less